Elke Bästlein

1.2k total citations
16 papers, 903 citations indexed

About

Elke Bästlein is a scholar working on Surgery, Genetics and Infectious Diseases. According to data from OpenAlex, Elke Bästlein has authored 16 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Elke Bästlein's work include Helicobacter pylori-related gastroenterology studies (10 papers), Inflammatory Bowel Disease (7 papers) and Veterinary medicine and infectious diseases (4 papers). Elke Bästlein is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Inflammatory Bowel Disease (7 papers) and Veterinary medicine and infectious diseases (4 papers). Elke Bästlein collaborates with scholars based in Germany, United States and Switzerland. Elke Bästlein's co-authors include Stephan Miehlke, Manfred Stolte, Norbert Lehn, E. Bayerdörffer, Wulf Schneider‐Brachert, B Bethke, Eberhard Meier, Ahmed Madisch, Christian Kirsch and Peter Heymer and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Scandinavian Journal of Gastroenterology.

In The Last Decade

Elke Bästlein

16 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elke Bästlein Germany 13 601 331 307 224 214 16 903
P. Godwin United Kingdom 9 463 0.8× 134 0.4× 170 0.6× 244 1.1× 105 0.5× 15 826
Kristiina M. Saarinen Finland 15 394 0.7× 69 0.2× 132 0.4× 78 0.3× 96 0.4× 20 1.2k
G L Swift United Kingdom 16 328 0.5× 462 1.4× 426 1.4× 208 0.9× 77 0.4× 34 887
Stephen C. Fiedorek United States 11 441 0.7× 274 0.8× 54 0.2× 65 0.3× 62 0.3× 26 640
GianMarco Giorgetti Italy 13 450 0.7× 411 1.2× 320 1.0× 128 0.6× 30 0.1× 30 738
Simona Di United Kingdom 13 415 0.7× 306 0.9× 33 0.1× 41 0.2× 122 0.6× 31 569
Giovanni Aragona Italy 15 499 0.8× 200 0.6× 39 0.1× 30 0.1× 176 0.8× 37 730
Günter Bode Germany 18 865 1.4× 304 0.9× 72 0.2× 25 0.1× 247 1.2× 29 1.0k
Vahid Hosseini Iran 10 291 0.5× 125 0.4× 42 0.1× 10 0.0× 123 0.6× 33 385
Craig Render Canada 3 610 1.0× 264 0.8× 59 0.2× 17 0.1× 230 1.1× 5 690

Countries citing papers authored by Elke Bästlein

Since Specialization
Citations

This map shows the geographic impact of Elke Bästlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Bästlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Bästlein more than expected).

Fields of papers citing papers by Elke Bästlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Bästlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Bästlein. The network helps show where Elke Bästlein may publish in the future.

Co-authorship network of co-authors of Elke Bästlein

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Bästlein. A scholar is included among the top collaborators of Elke Bästlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Bästlein. Elke Bästlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nikolaus, Susanna, Stefan Schreiber, Britta Siegmund, et al.. (2017). Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence. Journal of Crohn s and Colitis. 11(9). 1052–1062. 25 indexed citations
2.
Nikolaus, Susanna, Stefan Schreiber, Britta Siegmund, et al.. (2014). DOP044 Patient education in a 14 month randomized trial fails to improve adherence in ulcerative colitis: Influence of demographic and clinical parameters on non-adherence. Journal of Crohn s and Colitis. 8(9). S36–S36. 15 indexed citations
3.
Miehlke, Stephan, Wulf Schneider‐Brachert, Christian Kirsch, et al.. (2008). One‐Week Once‐Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin. Helicobacter. 13(1). 69–74. 46 indexed citations
4.
Madisch, Ahmed, Stephan Miehlke, B Bethke, et al.. (2007). Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. International Journal of Colorectal Disease. 22(12). 1445–1451. 80 indexed citations
5.
Miehlke, Stephan, Wulf Schneider‐Brachert, Christian Kirsch, et al.. (2006). Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Alimentary Pharmacology & Therapeutics. 24(2). 395–403. 73 indexed citations
6.
Antoš, David, Wulf Schneider‐Brachert, Elke Bästlein, et al.. (2006). 7‐Day Triple Therapy of Helicobacter pylori Infection with Levofloxacin, Amoxicillin, and High‐Dose Esomeprazole in Patients with Known Antimicrobial Sensitivity. Helicobacter. 11(1). 39–45. 67 indexed citations
7.
Madisch, Ahmed, Stephan Miehlke, B Bethke, et al.. (2005). Boswellia serrata Extrakt bei kollagener Kolitis-Eine randomisierte, placebo-kontrollierte, doppelblinde Multicenterstudie. Zeitschrift für Gastroenterologie. 43(5). 2 indexed citations
8.
Madisch, Ahmed, Peter Heymer, B Wigginghaus, et al.. (2004). Oral budesonide therapy improves quality of life in patients with collagenous colitis. International Journal of Colorectal Disease. 20(4). 312–316. 64 indexed citations
9.
Miehlke, Stephan, Wulf Schneider‐Brachert, Elke Bästlein, et al.. (2003). Esomeprazole‐based one‐week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Alimentary Pharmacology & Therapeutics. 18(8). 799–804. 20 indexed citations
10.
Miehlke, Stephan, Christian Kirsch, Wulf Schneider‐Brachert, et al.. (2003). A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and Clarithromycin. Helicobacter. 8(4). 310–319. 98 indexed citations
11.
Miehlke, Stephan, Peter Heymer, B Bethke, et al.. (2002). Budesonide treatment for collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 123(4). 978–984. 164 indexed citations
12.
Meining, Alexander, E. Bayerdörffer, Elke Bästlein, et al.. (1997). Focal Inflammatory Infiltrations in Gastric Biopsy Specimens Are Suggestive of Crohn's Disease. Scandinavian Journal of Gastroenterology. 32(8). 813–818. 36 indexed citations
13.
Miehlke, Stephan, E. Bayerdörffer, Norbert Lehn, et al.. (1996). Severity ofHelicobacter pyloriGastritis Predicts Duodenal Ulcer Recurrence. Scandinavian Journal of Gastroenterology. 31(9). 856–862. 8 indexed citations
14.
Bayerdörffer, E., Stephan Miehlke, Norbert Lehn, et al.. (1996). Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German gastric ulcer study. European Journal of Gastroenterology & Hepatology. 8(4). 343–350. 14 indexed citations
15.
Bayerdörffer, E., Stephan Miehlke, G. A. Mannes, et al.. (1995). Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology. 108(5). 1412–1417. 188 indexed citations
16.
Miehlke, Stephan, E. Bayerdörffer, Norbert Lehn, et al.. (1995). Risk prediction of duodenal ulcer relapse. Gastroenterology. 108(4). A167–A167. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Godwin Breakdown of academic impact, for papers by Kristiina M. Saarinen Breakdown of academic impact, for papers by G L Swift Breakdown of academic impact, for papers by Stephen C. Fiedorek Breakdown of academic impact, for papers by GianMarco Giorgetti Breakdown of academic impact, for papers by Simona Di Breakdown of academic impact, for papers by Giovanni Aragona Breakdown of academic impact, for papers by Günter Bode Breakdown of academic impact, for papers by Vahid Hosseini Breakdown of academic impact, for papers by Craig Render
Rankless by CCL
2026